Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study

References

• National Library of Medicine. Multiple sclerosis. Available from: https://medlineplus.gov/multiplesclerosis.html. Accessed January 18, 2024.
   Google Scholar
• Reich DS, Lucchinetti CF, Calabresi PA, Longo DL. Multiple sclerosis. N Engl J Med. 2018;378(2):169–180. doi:10.1056/NEJMra1401483
   PubMed Web of Science ®Google Scholar
• Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol. 2020;19(10):860–871. doi:10.1016/s1474-4422(20)30277-5
   PubMed Web of Science ®Google Scholar
• Strober L, Chiaravalloti N, Moore N, DeLuca J. Unemployment in multiple sclerosis (MS): utility of the MS functional composite and cognitive testing. Mult Scler. 2014;20(1):112–115. doi:10.1177/1352458513488235
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–1452. doi:10.1212/wnl.33.11.1444
   PubMed Web of Science ®Google Scholar
• Lloyd A, Schofield H, Adlard N. Cognitive decline may not be adequately captured in economic evaluations of multiple sclerosis: are new treatments being undervalued? Curr Med Res Opin. 2020;36(4):609–611. doi:10.1080/03007995.2020.1719393
   PubMed Web of Science ®Google Scholar
• Smith A. Symbol Digit Modalities Test (SDMT). Manual (Revised). Western Psychological Services; 1982.
   Google Scholar
• Benedict RH, DeLuca J, Phillips G, et al. Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult Scler. 2017;23(5):721–733. doi:10.1177/1352458517690821
   PubMed Web of Science ®Google Scholar
• Vadapalle S, Vudumula U, Gudala K, Adlard N. PND97 factors influencing health-related quality of life in patients with secondary progressive multiple sclerosis using expand trial data. Value Health. 2019;22:S755.
   Web of Science ®Google Scholar
• Morrow SA, Conway D, Fuchs T, et al. Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses. Mult Scler. 2021;27(7):1077–1087. doi:10.1177/1352458520973618
   PubMed Web of Science ®Google Scholar
• Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bul. 2010;96(1):5–21. doi:10.1093/bmb/ldq033
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. NICE health technology evaluations: the manual. Available from: https://www.nice.org.uk/process/pmg36/resources/nice-health-technology-evaluations-The-manual-pdf-72286779244741. Accessed January 18, 2024.
   Google Scholar
• Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: Canada - 4th edition. Available from: https://www.cadth.ca/sites/default/files/pdf/guidelines_for_the_economic_evaluation_of_health_technologies_canada_4th_ed.pdf. Accessed January 18, 2024.
   Google Scholar
• Haute Autorité de Santé. Choix méthodologiques pour l’évaluation économique à la HAS [Methodological choices for economic evaluation at HAS]. Available from: https://www.has-sante.fr/jcms/r_1499251/fr/choix-methodologiques-pour-l-evaluation-economique-A-la-has. Accessed January 18, 2024.
   Google Scholar
• López Bastida J, Oliva J, Antoñanzas F, et al. Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias [Proposal for a guide for economic evaluation applied to health technologies]. Gac Sanit. 2010;24(2):154–170. doi:10.1016/j.gaceta.2009.07.011
   PubMed Web of Science ®Google Scholar
• Merlin T, Tamblyn D, Schubert C. Guidelines for Preparing a Submission to the Pharmaceutical Benefits Advisory Committee, Version 5.0. Australian Government, Department of health; 2016.
   Google Scholar
• China Guidelines for Pharmacoeconomic Evaluations Working Group. China guidelines for pharmacoeconomic evaluations. Available from: https://tools.ispor.org/PEguidelines/source/China-Guidelines-for-Pharmacoeconomic-Evaluations-2020.pdf. Accessed January 18, 2024.
   Google Scholar
• Shiroiwa T, Fukuda T, Ikeda S, Takura T, Moriwaki K. Development of an official guideline for the economic evaluation of drugs/medical devices in Japan. Value Health. 2017;20(3):372–378. doi:10.1016/j.jval.2016.08.726
   PubMed Web of Science ®Google Scholar
• Geraerds A, Bonsel GJ, Janssen MF, et al. The added value of the EQ-5D with a cognition dimension in injury patients with and without traumatic brain injury. Qual Life Res. 2019;28(7):1931–1939. doi:10.1007/s11136-019-02144-6
   PubMed Web of Science ®Google Scholar
• Finch AP, Brazier J, Mukuria C. Selecting bolt-on dimensions for the EQ-5D: testing the impact of hearing, sleep, cognition, energy, and relationships on preferences using pairwise choices. Med Decis Making. 2021;41(1):89–99. doi:10.1177/0272989x20969686
   PubMed Web of Science ®Google Scholar
• Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goni JM, Luo N. EuroQol protocols for time trade-off valuation of health outcomes. PharmacoEconomics. 2016;34(10):993–1004. doi:10.1007/s40273-016-0404-1
   PubMed Web of Science ®Google Scholar
• Office for National Statistics. Population estimates for the UK, England and Wales, Scotland and Northern Ireland: mid-2018. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/annualmidyearpopulationestimates/latest. Accessed January 18, 2024.
   Google Scholar
• Office for National Statistics. Population estimates by marital status and living arrangements, England and Wales. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesbymaritalstatusandlivingarrangements. Accessed January 18, 2024.
   Google Scholar
• Office for National Statistics. Highest level of qualification achieved by people living in UK regions, 2010 to 2018. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/educationandchildcare/adhocs/10516highestlevelofqualificationachievedbypeoplelivinginukregions2010to2018. Accessed January 18, 2024.
   Google Scholar
• Office for National Statistics. Employment in the UK; 2019. Available from: https://www.ons.gov.uk/employmentandlabourmarket/peopleinwork/employmentandemployeetypes/bulletins/employmentintheuk/december2019. Accessed January 18, 2024.
   Google Scholar
• Strober LB, Bruce JM, Arnett PA, et al. A new look at an old test: normative data of the symbol digit modalities test -oral version. Mult Scler Relat Disord. 2020;43:102154. doi:10.1016/j.msard.2020.102154
   PubMed Web of Science ®Google Scholar
• Nicholas RS, Heaven ML, Middleton RM, et al. Personal and societal costs of multiple sclerosis in the UK: a population-based MS registry study. Mult Scler J Exp Transl Clin. 2020;6(1):2055217320901727. doi:10.1177/2055217320901727
   Google Scholar
• Montgomery S, Woodhouse F, Vudumula U, Gudala K, Duddy M, Kroes M. Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UK. J Med Econ. 2022;25(1):669–678. doi:10.1080/13696998.2022.2078103
   PubMed Web of Science ®Google Scholar
• Benedict RHB, Tomic D, Cree BA, et al. Siponimod and cognition in secondary progressive multiple sclerosis: EXPAND secondary analyses. Neurology. 2021;96(3):e376–e386. doi:10.1212/wnl.0000000000011275
   PubMed Web of Science ®Google Scholar
• MS Trust. Expanded Disability Status Scale (EDSS). Available from: https://www.mstrust.org.uk/a-z/expanded-disability-status-scale-edss. Accessed January 18, 2024.
   Google Scholar
• Braisch U, Muche R, Rothenbacher D, Landwehrmeyer GB, Long JD, Orth M. Identification of symbol digit modality test score extremes in Huntington’s disease. Am J Med Genet B Neuropsychiatr Genet. 2019;180(3):232–245. doi:10.1002/ajmg.b.32719
   PubMed Web of Science ®Google Scholar
• Tolley K. What are health utilities? Available from: http://www.bandolier.org.uk/painres/download/What%20is%202009/What_are_health_util.pdf. Accessed January 18, 2024.
   Google Scholar